Alerts will be sent to your verified email
Verify EmailTRIMURTHI
Novelix Pharma
|
Yash Chemex
|
Roni Households
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-17.5 % | 7.71 % | -2.41 % |
5yr average Equity Multiplier
|
1.26 | 2.48 | 2.33 |
5yr Average Asset Turnover Ratio
|
0.84 | 1.26 | 0.56 |
5yr Avg Net Profit Margin
|
-14.11 % | 2.39 % | -0.74 % |
Price to Book
|
8.2 | 1.7 | 3.66 |
P/E
|
102.99 | 37.9 | 93.23 |
5yr Avg Cash Conversion Cycle
|
29.1 Days | 150.3 Days | 377.84 Days |
Inventory Days
|
34.04 Days | 40.13 Days | 143.96 Days |
Days Receivable
|
55.38 Days | 144.23 Days | 339.45 Days |
Days Payable
|
55.7 Days | 93.72 Days | 249.67 Days |
5yr Average Interest Coverage Ratio
|
-17.77 | 8.19 | 2.6 |
5yr Avg ROCE
|
-15.4 % | 11.71 % | 1.67 % |
5yr Avg Operating Profit Margin
|
-16.49 % | 2.5 % | 5.35 % |
5 yr average Debt to Equity
|
0.05 | 0.28 | 0.46 |
5yr CAGR Net Profit
|
35.78 % | n/a | n/a |
5yr Average Return on Assets
|
-13.36 % | 3.01 % | 0.18 % |
Shareholdings
|
|||
Promoter Holding
|
52.75 % | 64.38 % | 60.11 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-14.17 % | 4.48 % | -5.29 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Novelix Pharma
|
Yash Chemex
|
Roni Households
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|